文献速递肝病消化道肿瘤与早癌

胆道闭锁患儿生存相关基因表达特征及潜在治疗药物

Gene Expression Signatures Associated With Survival Times of Pediatric Patients With Biliary Atresia Identify Potential Therapeutic Agents.
PubMed 文献 · Gastroenterology · 2019-06-19

该研究对胆道闭锁患儿肝活检mRNA测序,发现14个基因表达特征与24月龄无肝移植生存相关,联合术后3月胆红素预测AUC在发现集0.948、验证集0.813。小鼠模型中NAC减轻肝损伤和纤维化并延长生存。

要点

  • 14个mRNA表达特征与胆道闭锁患儿24月龄无移植生存相关(P < .001)。
  • 该特征联合术后3月胆红素预测24月龄生存的AUC发现集0.948、验证集0.813(P < .001)。
  • NAC在胆道闭锁小鼠中减轻肝损伤、减少胆管梗阻和纤维化并延长生存。

核心结论

  • 胆道闭锁患儿肝组织14基因表达特征与24月龄无肝移植生存相关,联合术后3月胆红素可提高预测。
  • 促进谷胱甘肽代谢的药物如NAC可能被开发用于胆道闭锁治疗。

研究设计与样本

  • 肝活检和临床数据来自胆汁淤积婴儿及无肝病儿童(对照),mRNA随机分为发现集(n = 121)和验证集(n = 50)行RNA测序。
  • 用Superpc R包和Cox回归分析寻找与24月龄无肝移植生存相关的基因表达谱。
  • 在BALB/c小鼠腹腔注射A型恒河猴轮状病毒诱导胆道闭锁,注射抗氧化剂NAC或锰(III)四(4-苯甲酸)卟啉。

主要发现

  • 发现14个mRNA表达模式与较短vs较长生存时间相关(P < .001)。
  • 该特征联合肝门空肠吻合术后3月胆红素水平预测24月龄生存的AUC发现集0.948、验证集0.813(P < .001)。
  • 肝硬化相关转录组与无移植生存时间缩短相关,包括细胞外基质调节基因激活及活化的星状细胞和门管区成纤维细胞数量。
  • 2年无移植生存患者肝组织中高表达的许多mRNA谷胱甘肽代谢评分富集。
  • 胆道闭锁小鼠中仅NAC减少肝损伤组织学特征及血清转氨酶、γ-谷氨酰转移酶和胆红素水平,并减少胆管梗阻和肝纤维化、延长生存时间。

关键数值与推荐

  • 14个mRNA表达特征与较短vs较长生存时间相关(P < .001)。
  • 联合术后3月胆红素预测24月龄生存的AUC发现集0.948、验证集0.813(P < .001)。

临床怎么用

  • 肝组织14基因表达特征联合术后3月胆红素可能用于预测胆道闭锁患儿24月龄无肝移植生存。
  • NAC在胆道闭锁小鼠中减少肝损伤和纤维化并延长生存,提示促进谷胱甘肽代谢的药物可能被开发用于治疗。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Little is known about the factors that affect outcomes of patients with biliary atresia and there are no medical therapies that increase biliary drainage. METHODS: Liver biopsies and clinical data were obtained from infants with cholestasis and from children without liver disease (controls); messenger RNA (mRNA) was isolated, randomly assigned to discovery (n = 121) and validation sets (n = 50), and analyzed by RNA sequencing. Using the Superpc R package followed by Cox regression analysis, we sought to identify gene expression profiles that correlated with survival without liver transplantation at 24 months of age. We also searched for combinations of gene expression patterns, clinical factors, and laboratory results obtained at diagnosis and at 1 and 3 months after surgery that associated with transplant-free survival for 24 months of age. We induced biliary atresia in BALB/c mice by intraperitoneal administration of Rhesus rotavirus type A. Mice were given injections of the antioxidants N-acetyl-cysteine (NAC) or manganese (III) tetrakis-(4-benzoic acid)porphyrin. Blood and liver tissues were collected and analyzed by histology and immunohistochemistry. RESULTS: We identified a gene expression pattern of 14 mRNAs associated with shorter vs longer survival times in the discovery and validation sets (P < .001). This gene expression signature, combined with level of bilirubin 3 months after hepatoportoenterostomy, identified children who survived for 24 months with an area under the curve value of 0.948 in the discovery set and 0.813 in the validation set (P < .001). Computer models correlated a cirrhosis-associated transcriptome with decreased times of transplant-free survival; this transcriptome included activation of genes that regulate the extracellular matrix and numbers of activated stellate cells and portal fibroblasts. Many mRNAs expressed at high levels in liver tissues from patients with 2-year transplant-free survival had enriched scores for glutathione metabolism. Among mice with biliary atresia given injections of antioxidants, only NAC reduced histologic features of liver damage and serum levels of aminotransferase, gamma-glutamyl transferase, and bilirubin. NAC also reduced bile duct obstruction and liver fibrosis and increased survival times. CONCLUSIONS: In studies of liver tissues from infants with cholestasis, we identified a 14-gene expression pattern that associated with transplant-free survival for 2 years. mRNAs encoding proteins that regulate fibrosis genes were increased in liver tissues from infants who did not survive for 2 years, whereas mRNAs that encoded proteins that regulate glutathione metabolism were increased in infants who survived for 2 years. NAC reduced liver injury and fibrosis in mice with biliary atresia, and increased survival times. Agents such as NAC that promote glutathione metabolism might be developed for treatment of biliary atresia.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Luo Z, Shivakumar P, Mourya R, et al. Gene Expression Signatures Associated With Survival Times of Pediatric Patients With Biliary Atresia Identify Potential Therapeutic Agents. Gastroenterology. 2019. PMID: 31228442. doi:10.1053/j.gastro.2019.06.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。